Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom
The Pediatric Infectious Disease Journal, 06/01/2012
Findlow H et al. – A single priming dose of either meningococcal C conjugate (MCC)–TT or MCC–CRM197 administered at 3 months of age can be used together with the Hib/MCC–TT booster in the second year of life.



